These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 11164910

  • 1. Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.
    Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I.
    J Neuroimmunol; 2001 Feb 15; 113(2):260-7. PubMed ID: 11164910
    [Abstract] [Full Text] [Related]

  • 2. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
    Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I.
    Brain; 2000 Jan 15; 123 ( Pt 1)():116-24. PubMed ID: 10611126
    [Abstract] [Full Text] [Related]

  • 3. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
    Yuki N.
    Lancet Infect Dis; 2001 Aug 15; 1(1):29-37. PubMed ID: 11871407
    [Abstract] [Full Text] [Related]

  • 4. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N.
    Ann Neurol; 2000 Oct 15; 48(4):624-31. PubMed ID: 11026446
    [Abstract] [Full Text] [Related]

  • 5. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
    Ang CW, Yuki N, Jacobs BC, Koga M, Van Doorn PA, Schmitz PI, Van Der Meché FG.
    Neurology; 1999 Dec 10; 53(9):2122-7. PubMed ID: 10599792
    [Abstract] [Full Text] [Related]

  • 6. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 Dec 10; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 7. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 8. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K, Ohnishi A, Hashimoto T, Yuki N.
    Rinsho Shinkeigaku; 1997 Feb 18; 37(2):106-10. PubMed ID: 9164140
    [Abstract] [Full Text] [Related]

  • 9. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S.
    J Neuroimmunol; 2007 Jan 18; 182(1-2):212-8. PubMed ID: 17113161
    [Abstract] [Full Text] [Related]

  • 10. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G, Kaida K, Kuwahara M, Kimura F, Kamakura K, Kusunoki S.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):141-5. PubMed ID: 23000056
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J, Koga M, Funakoshi K, Kirschner J, Muellges W, Weishaupt A, Gold R, Korinthenberg R.
    Arch Dis Child; 2007 Jan 15; 92(1):48-52. PubMed ID: 16920757
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S, Ogawara K, Misawa S, Koga M, Mori M, Hiraga A, Kanesaka T, Hattori T, Yuki N.
    Neurology; 2004 Aug 10; 63(3):529-33. PubMed ID: 15304587
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
    Odaka M, Koga M, Yuki N, Susuki K, Hirata K.
    J Neurol Sci; 2003 Jun 15; 210(1-2):99-103. PubMed ID: 12736097
    [Abstract] [Full Text] [Related]

  • 17. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
    Koga M, Yuki N, Hirata K.
    J Neuroimmunol; 1999 May 03; 96(2):245-50. PubMed ID: 10337924
    [Abstract] [Full Text] [Related]

  • 18. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N.
    J Neuroimmunol; 2006 Aug 03; 177(1-2):201-8. PubMed ID: 16844234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A, Briani C, Wirguin I, Siciliano G, D'Avino C, Latov N.
    J Neurol Sci; 2002 Apr 15; 196(1-2):41-4. PubMed ID: 11959155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.